Aflac Incorporated 10-Q Summary: Period Ended June 30, 2005
Business Context and Reporting Period
This is a quarterly report (Form 10-Q) for Aflac Incorporated, a provider of supplemental health and life insurance primarily in the United States and Japan. The reporting period covers the three and six months ended June 30, 2005. The financial statements are unaudited but have been reviewed by KPMG LLP. The Company adopted Statement of Financial Accounting Standards (SFAS) No. 123(R) regarding share-based payments effective January 1, 2005, and prior year results have been adjusted to reflect this change.
Key Financial Metrics
| Metric (Six Months Ended June 30) | 2005 ($ millions) | 2004 ($ millions) |
|---|---|---|
| Total Revenues | 7,127 | 6,513 |
| Premiums | 6,061 | 5,541 |
| Net Investment Income | 1,033 | 957 |
| Net Earnings | 664 | 563 |
| Diluted EPS | $1.30 | $1.09 |
| Operating Cash Flow | 2,356 | 2,249 |
| Total Assets | 57,995 | 59,326 |
| Shareholders' Equity | 8,459 | 7,576 |
| Notes Payable | 1,369 | 1,429 |
Margins and Ratios: The combined effective income tax rate was 35.1% for the six months ended June 30, 2005, compared to 36.1% in 2004. The debt-to-total capitalization ratio was 19.9% as of June 30, 2005.
Material Changes vs. Prior Period
- Revenue Growth: Total revenues increased 9.4% year-over-year, driven by a 9.4% increase in premiums and a 7.9% increase in net investment income.
- Earnings Growth: Net earnings rose 17.9% to $664 million, with diluted EPS increasing 19.3% to $1.30.
- Segment Performance:
- Aflac Japan: Pretax operating earnings increased 15.9% to $787 million. Premium income grew 8.9% in dollars (6.5% in yen). The segment benefited from favorable claim trends and a shift to newer products with lower benefit ratios.
- Aflac U.S.: Pretax operating earnings increased 9.0% to $263 million. Premium income grew 10.7% in dollars, supported by strong sales in accident/disability and hospital indemnity products.
- Foreign Currency Impact: The yen weakened against the dollar (from 104.21 to 110.62), reducing reported assets and liabilities by approximately $2.8 billion and $2.7 billion, respectively, compared to year-end 2004. This translation effect suppressed reported growth rates in dollar terms.
- Investment Portfolio: The Company held $4.9 billion in net unrealized gains on debt securities. Privately issued securities accounted for 65.6% of total debt securities at amortized cost.
Guidance, Outlook, and Risks
- Earnings Guidance: Management's objective for 2005 is to achieve net earnings per diluted share of at least $2.56, representing a 14.8% increase over 2004. This projection assumes no impact from foreign currency translation, no realized investment gains/losses, and no impact from SFAS 133.
- Future Objectives: The Company targets a 15% increase in diluted EPS for 2006 and a 13% to 16% increase for 2007.
- Sales Targets: Aflac Japan aims to increase total new annualized premium sales in yen by 5% to 10% for 2005. Aflac U.S. targets a 3% to 8% increase in total new annualized premium sales.
- Risks and Contingencies:
- Currency Risk: Fluctuations in the yen/dollar exchange rate significantly impact reported results. The Company uses cross-currency swaps and yen-denominated debt to hedge its net investment in Aflac Japan.
- Interest Rate Risk: A 100 basis point increase in market interest rates could reduce the fair value of debt securities by approximately $4.8 billion.
- Investment Credit Risk: The portfolio includes privately issued securities. While all are investment grade at purchase, the Company monitors credit quality closely. Below-investment-grade securities totaled $790 million at amortized cost.
- Regulatory: Dividends from Aflac Japan are subject to Japanese regulatory restrictions to ensure sufficient financial strength for policyholders.
- Unusual Items: A $18 million pre-tax charge was recorded in Aflac Japan for the write-down of previously capitalized systems development costs. The Company also recognized a $6 million gain in 2004 related to a Japanese pension obligation transfer, which did not recur in 2005.
Key Facts for Investor Verification
- Verify the sustainability of the 15.9% growth in Aflac Japan's pretax operating earnings, considering the impact of the yen/dollar exchange rate and the one-time $18 million software write-down.
- Monitor the Company's ability to meet its 2005 EPS target of $2.56, which relies on assumptions of zero foreign currency translation impact and no realized investment gains/losses.
- Review the composition of the investment portfolio, specifically the 65.6% allocation to privately issued securities and the $790 million in below-investment-grade holdings, to assess credit risk exposure.
- Track the effectiveness of the Company's hedging strategies against currency fluctuations, as the yen weakened significantly during the period.
- Confirm the progress of new agent recruitment and sales growth in both Japan and the U.S. against the stated annual targets.